Related Experiment Video
Updated: Sep 3, 2025

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
Published on: February 2, 2024
Clinical Profile of Monomicrobial Corynebacterium Hip and Knee Periprosthetic Joint Infections
Hussam Tabaja1, Don Bambino Geno Tai1, Elena Beam1
1Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Background:
Corynebacterium periprosthetic joint infection (PJI) is a poorly described infectious syndrome. Prior studies included cases of polymicrobial infections. This series describes the clinical characteristics, management, and outcomes of monomicrobial Corynebacterium PJI.
Methods:
We queried the Mayo Clinic Total Joint Registry for cases of monomicrobial Corynebacterium knee and hip PJI in adults (age ≥18 years) between 2010 and 2019.
Results:
A total of 20 (1%) out of 2067 PJI cases met our inclusion criteria. Most were males (55%), and the median age was 64 years. Seventy percent had chronic symptoms (>4 weeks). PJI was delayed to late (>3 months postimplantation) in 90%. Three species were identified: C. striatum (70%), C. jeikeium (20%), and C. amycolatum (10%). All tested isolates were susceptible to vancomycin (100%) and linezolid (100%), and most had a minimum inhibitory concentration ≤0.06 mcg/mL to daptomycin (75%). Other agents were less reliable, with high resistance to oral agents commonly used for suppression. Nineteen patients were treated: 37% debridement and implant retention (DAIR), 47% 2-stage exchange, and 16% resection without reimplantation. Of these, failure occurred in 29%, 11%, and 0%, respectively.
Conclusions:
Corynebacterium PJIs pose a therapeutic challenge due to limited antimicrobial armamentarium and undefined optimal surgical intervention. Vancomycin and linezolid remain the most reliable agents for treatment. DAIR may be attempted for acute PJI, but verification of durable chronic suppression options will be critical for this approach.
Insights
Monomicrobial Corynebacterium periprosthetic joint infection (PJI) is challenging to treat. Vancomycin and linezolid are effective, while debridement and implant retention (DAIR) may be suitable for acute cases.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Microbiology
Background:
- Corynebacterium periprosthetic joint infection (PJI) is an under-described infectious syndrome.
- Previous studies often included polymicrobial infections, obscuring Corynebacterium-specific characteristics.
- This study focuses on monomicrobial Corynebacterium PJI cases.
Purpose of the Study:
- To describe the clinical features of monomicrobial Corynebacterium PJI.
- To evaluate management strategies and patient outcomes.
- To identify effective antimicrobial and surgical treatments.
Main Methods:
- Retrospective query of the Mayo Clinic Total Joint Registry.
- Inclusion of adult patients with monomicrobial Corynebacterium knee or hip PJI (2010-2019).
- Analysis of clinical data, microbial species, antimicrobial susceptibility, and treatment outcomes.
Main Results:
- 20 cases (1%) of monomicrobial Corynebacterium PJI were identified.
- Most patients were male (55%), median age 64, with 70% experiencing chronic symptoms (>4 weeks).
- 90% of PJIs were late (>3 months postimplantation), predominantly C. striatum (70%). Vancomycin and linezolid showed 100% susceptibility; daptomycin was effective in 75%.
Conclusions:
- Corynebacterium PJIs present therapeutic challenges due to limited antibiotic options and unclear surgical management.
- Vancomycin and linezolid are the most reliable antimicrobial agents.
- Debridement and implant retention (DAIR) might be considered for acute PJI, but long-term suppression strategies require further investigation.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pyelonephritis I: Introduction
Endocarditis I: Introduction
Bacterial Phylum Actinobacteria
Endocarditis II: Clinical Features of Infective Endocarditis
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

